A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
Clinical trial NCT03917225 · COMPLETED
Trial details
- NCT number
- NCT03917225
- Sponsor
- Minoryx Therapeutics, S.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2020-08-13
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.